Komori
Kissei Pharmaceutical (4547) · InitiativeReframed

Management Oversight by the CEO and Division of Execution Responsibilities with the COO

First written in FY2016. 5 of 9 entries say "Restated". Latest entry: FY2026.

9entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 120222023: 020232024: 120242025: 020252026: 32026
Same theme, other companies
Management and execution structure through separation of CEO and COO roles and authorityA theme 8 companies write about · 0 as a headwind · 8 as a tailwind

2 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「Representative Director and President Chief Operating Officer (COO) Miyazawa Keiji (宮澤 敬治) June 2026 Appointed representative director and president of the company (current)」

    The framework under which the CEO oversees overall management as chairperson and the COO is responsible for business execution will be maintained, while the COO and representative director and president after the annual general meeting of shareholders are scheduled to change from Takehana Yasuo (竹花 泰雄) to Miyazawa Keiji (宮澤 敬治).
  2. FY2024RestatedAnnual report

    「The representative director and chairperson, as CEO, oversees overall management, while the representative director and president, as COO, is responsible for executing operations across the business.」

    The company has reconfirmed the division of management oversight and execution responsibilities between the CEO and COO.
  3. FY2022RestatedAnnual report

    「The representative director and chairperson, who is the Chief Executive Officer (CEO), oversees overall management, while the representative director and president, who is the Chief Operating Officer (COO), is responsible for executing operations across the business.」

    The company has reconfirmed the division of management oversight and execution responsibilities between the chairperson as CEO and the president as COO.
  4. FY2019RestatedAnnual report

    「The representative director and chairperson, who is the Chief Executive Officer (CEO), oversees overall management, while the representative director and president, who is the Chief Operating Officer (COO), is responsible for executing operations across the business.」

    The company has reconfirmed the division of management oversight and execution responsibilities between the chairperson as CEO and the president as COO.
  5. FY2018RestatedAnnual report

    「The representative director and chairperson serves as Chief Executive Officer (CEO), overseeing overall management, while the representative director and president serves as Chief Operating Officer (COO), responsible for executing operations across the business.」

    The company has reconfirmed its management oversight and execution structure based on the division of roles between the chairperson as CEO and the president as COO.
  6. FY2017RestatedAnnual report

    「The representative director and chairperson serves as Chief Executive Officer (CEO), overseeing overall management, while the representative director and president serves as Chief Operating Officer (COO), responsible for executing operations across the business.」

    The company has reconfirmed its management oversight and execution structure based on the division of roles between the CEO and COO.
  7. FY2016First statedAnnual report

    「The representative director and chairperson serves as Chief Executive Officer (CEO), overseeing overall management, while the representative director and president serves as Chief Operating Officer (COO), responsible for executing operations across the business.」

    The company is strengthening management agility and its execution structure through the division of roles between the CEO and COO, the executive committee and business execution meetings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kissei Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Earnings of 2026-05-11: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Management Oversight by the CEO and Division of Execution Responsibilities with the COO | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | Komori